LGT Fund Management Co Ltd. Takes Position in Alignment Healthcare, Inc. $ALHC

Key Points

• LGT Fund Management Co Ltd. acquired a new stake in Alignment Healthcare, purchasing approximately 151,500 shares valued at about $2.12 million, representing 0.08% ownership of the company.
• Recent insider sales included executives Robert L. Scavo and Christopher J. Joyce, who sold shares totaling nearly $992,378, indicating a decrease in their individual positions by approximately 4.91% and 8.26%, respectively.
• Analysts have mixed ratings on Alignment Healthcare, with two providing a Strong Buy rating and others setting a consensus target price of $18.83 for the stock.

LGT Fund Management Co Ltd. bought a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 151,500 shares of the company's stock, valued at approximately $2,121,000. LGT Fund Management Co Ltd. owned approximately 0.08% of Alignment Healthcare at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. 111 Capital bought a new stake in shares of Alignment Healthcare during the 2nd quarter valued at $325,000. Hennessy Advisors Inc. bought a new stake in shares of Alignment Healthcare during the 2nd quarter valued at $7,853,000. Greenleaf Trust bought a new stake in shares of Alignment Healthcare during the 2nd quarter valued at $160,000. Signaturefd LLC boosted its holdings in shares of Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company's stock valued at $53,000 after buying an additional 2,215 shares in the last quarter. Finally, Ballentine Partners LLC boosted its holdings in shares of Alignment Healthcare by 10.2% during the 2nd quarter. Ballentine Partners LLC now owns 12,862 shares of the company's stock valued at $180,000 after buying an additional 1,188 shares in the last quarter. Institutional investors own 86.19% of the company's stock.

Insiders Place Their Bets

In other Alignment Healthcare news, insider Robert L. Scavo sold 29,535 shares of the business's stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $484,669.35. Following the completion of the transaction, the insider owned 572,555 shares of the company's stock, valued at approximately $9,395,627.55. The trade was a 4.91% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Christopher J. Joyce sold 30,939 shares of the business's stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $507,708.99. Following the completion of the transaction, the insider directly owned 343,592 shares of the company's stock, valued at approximately $5,638,344.72. This trade represents a 8.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,388,173 shares of company stock worth $118,068,256 in the last quarter. Insiders own 7.00% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on ALHC shares. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target on the stock in a research note on Monday, August 25th. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Zacks Research upgraded shares of Alignment Healthcare from a "hold" rating to a "strong-buy" rating in a research note on Monday, September 29th. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Alignment Healthcare in a research note on Saturday, September 27th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Alignment Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $18.83.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $16.62 on Friday. Alignment Healthcare, Inc. has a fifty-two week low of $10.11 and a fifty-two week high of $21.06. The business has a 50-day simple moving average of $15.59 and a two-hundred day simple moving average of $15.67. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a market cap of $3.29 billion, a price-to-earnings ratio of -59.36 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. During the same quarter in the previous year, the firm earned ($0.13) EPS. Alignment Healthcare's revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.